Marathoner on Pace to Beat MS

Apr 13, 2001, 01:00 ET from Teva Neuroscience LLC

    BOSTON, April 13 /PRNewswire/ -- While others ran against the clock and
 the crowd, Wendy Booker ran against a hidden competitor:  multiple sclerosis
 (MS).  She crossed the line of her first marathon in four hours and 46
 minutes.  She didn't break a race record, but she beat the perceptions
 associated with MS.  On April 16, Wendy will lace up her sneakers to go after
 a personal record and to raise awareness for her personal fight.
 
     True Grit
     After finishing her first marathon, Wendy Booker was unsure if she would
 ever run 26.2 miles again.  Her training partner and lifelong friend, Carol,
 had sworn off another marathon.  Wendy feared the early morning training runs
 by herself and the grueling mental torture of race day.  Instead she focused
 on what her running means in the bigger picture.
     "This year I am focused on more than just finishing the race.  I want
 everyone to know what people living with this disease can do.  I want to be an
 inspiration for others living with MS," said Booker.
     In 2000, Wendy teamed up with Carol, the National MS Society - Central New
 England Chapter "Marathon Strides Against MS" team, and Team COPAXONE(R)
 (glatiramer acetate for injection).  Through her partnerships, friends,
 family, and various, generous donors, Wendy raised more than $8,000 for the
 NMSS and MS research.  She hopes to duplicate her success and add to her
 fundraising total in 2001.
     "I never would have run a marathon had I not been diagnosed with MS.  To
 run successfully, you really have to want it.  You need something deep from
 within to accomplish it," said Booker.  "All the runners I know have their own
 agenda for taking on a marathon, mine was MS.  This year, I want to run faster
 and raise more money while challenging the perceptions of what people living
 with MS can do. "
 
     Racing the Disease
     When Booker was diagnosed with relapsing-remitting multiple sclerosis
 (RRMS) in June 1998, she knew very little about the disease and its effects.
 Booker feared she would lose the ability to do the one thing she loved most --
 run.  To put her mind at ease, she learned all she could about the disease and
 its symptoms.  She thought the more she learned, the better she would be
 mentally and physically.  Now, Booker is helping others learn about her
 success.  In 2000, she traveled across the country and spoke to others living
 with MS.
     "After the race, I wanted people to know my story and see that they could
 still achieve personal goals, like a marathon, even though they have MS," said
 Booker.  "I have had many people come up to me and say they were afraid of
 what life would be like after the diagnosis, but now they are planning the
 vacation they have always dreamed of or getting back into gardening, all sorts
 of things.  I feel fortunate that I have been able to connect with others
 living with MS."
     Booker talks to others about her experience with MS and directs audiences
 to resources like Shared Solutions(TM), the National Multiple Sclerosis
 Society, and MSWatch(R).  Each one provided her with the answers she needed to
 come to terms with her diagnosis.
 
     Advances in Medicine
     Advances in medicine have led neurologists to treatments that can modify
 the immune processes thought to be responsible for relapsing-remitting
 multiple sclerosis.  The FDA has approved drugs, such as COPAXONE(R)
 (glatiramer acetate for injection) that Booker takes.  COPAXONE(R) helps
 reduce the frequency of relapses in people with relapsing-remitting multiple
 sclerosis.  While individual results may vary, she has not suffered a relapse
 since 1998.
     The most common side effects of COPAXONE(R) are redness, pain, swelling,
 itching, or a lump at the site of injection, flushing, chest pain, weakness,
 infection, pain, nausea, joint pain, anxiety, and muscle stiffness.  These
 reactions are usually mild and seldom require professional treatment. Patients
 should tell their doctor about any
 side effects.
     Some patients report a short-term reaction right after injecting
 COPAXONE(R) (glatiramer acetate for injection).  This reaction can involve
 flushing (feeling of warmth and/or redness), chest tightness, or pain with
 heart palpitations, anxiety, and trouble breathing.  These symptoms generally
 appear within minutes of an injection, last about 15 minutes, and go away by
 themselves without further problems.
 
     Team COPAXONE(R)
     Booker is a member of Team COPAXONE(R).  She is just one example of
 someone who is living with relapsing-remitting multiple sclerosis and pursuing
 her dreams.  Team COPAXONE(R) celebrates the accomplishments of people like
 Booker who refuse to let MS stand in their way.  Members are working to change
 the perceptions that society holds of people living with multiple sclerosis.
 The days when people were sent home and told to go to bed and prepare for a
 wheelchair are at last disappearing.  Today a combination of lifestyle
 changes, medical management, and will power are helping people like Booker to
 live out their dreams.
     "Each mile that I run makes me feel empowered and proud of how I am
 managing my disease instead of letting it manage me," Booker stated.  "The
 26.2 miles in the Boston Marathon will help me demonstrate that those of us
 living with MS don't have to give up the things we love.  For me, that is
 running."
     Call 1-800-887-8100 for more information about COPAXONE(R) or multiple
 sclerosis.  Teva Neuroscience LLC markets COPAXONE(R).
     See additional important information at
 http://www.copaxone.com/pi/index.html or call 1-800-887-8100.
     COPAXONE(R) is a registered trademark of Teva Pharmaceutical Industries,
 Ltd.
     MSWatch(R) and Shared Solutions(TM) are trademarks of Teva Neuroscience
 LLC.
     323203/8372C1
     For product information, please call 1-800-753-0352 ext.738.
 
     CONTACT:  Jennifer Westphal of Fleishman-Hillard, 816-512-2241,
 westphaj@fleishman.com , for Teva Neuroscience LLC.
 
 

SOURCE Teva Neuroscience LLC
    BOSTON, April 13 /PRNewswire/ -- While others ran against the clock and
 the crowd, Wendy Booker ran against a hidden competitor:  multiple sclerosis
 (MS).  She crossed the line of her first marathon in four hours and 46
 minutes.  She didn't break a race record, but she beat the perceptions
 associated with MS.  On April 16, Wendy will lace up her sneakers to go after
 a personal record and to raise awareness for her personal fight.
 
     True Grit
     After finishing her first marathon, Wendy Booker was unsure if she would
 ever run 26.2 miles again.  Her training partner and lifelong friend, Carol,
 had sworn off another marathon.  Wendy feared the early morning training runs
 by herself and the grueling mental torture of race day.  Instead she focused
 on what her running means in the bigger picture.
     "This year I am focused on more than just finishing the race.  I want
 everyone to know what people living with this disease can do.  I want to be an
 inspiration for others living with MS," said Booker.
     In 2000, Wendy teamed up with Carol, the National MS Society - Central New
 England Chapter "Marathon Strides Against MS" team, and Team COPAXONE(R)
 (glatiramer acetate for injection).  Through her partnerships, friends,
 family, and various, generous donors, Wendy raised more than $8,000 for the
 NMSS and MS research.  She hopes to duplicate her success and add to her
 fundraising total in 2001.
     "I never would have run a marathon had I not been diagnosed with MS.  To
 run successfully, you really have to want it.  You need something deep from
 within to accomplish it," said Booker.  "All the runners I know have their own
 agenda for taking on a marathon, mine was MS.  This year, I want to run faster
 and raise more money while challenging the perceptions of what people living
 with MS can do. "
 
     Racing the Disease
     When Booker was diagnosed with relapsing-remitting multiple sclerosis
 (RRMS) in June 1998, she knew very little about the disease and its effects.
 Booker feared she would lose the ability to do the one thing she loved most --
 run.  To put her mind at ease, she learned all she could about the disease and
 its symptoms.  She thought the more she learned, the better she would be
 mentally and physically.  Now, Booker is helping others learn about her
 success.  In 2000, she traveled across the country and spoke to others living
 with MS.
     "After the race, I wanted people to know my story and see that they could
 still achieve personal goals, like a marathon, even though they have MS," said
 Booker.  "I have had many people come up to me and say they were afraid of
 what life would be like after the diagnosis, but now they are planning the
 vacation they have always dreamed of or getting back into gardening, all sorts
 of things.  I feel fortunate that I have been able to connect with others
 living with MS."
     Booker talks to others about her experience with MS and directs audiences
 to resources like Shared Solutions(TM), the National Multiple Sclerosis
 Society, and MSWatch(R).  Each one provided her with the answers she needed to
 come to terms with her diagnosis.
 
     Advances in Medicine
     Advances in medicine have led neurologists to treatments that can modify
 the immune processes thought to be responsible for relapsing-remitting
 multiple sclerosis.  The FDA has approved drugs, such as COPAXONE(R)
 (glatiramer acetate for injection) that Booker takes.  COPAXONE(R) helps
 reduce the frequency of relapses in people with relapsing-remitting multiple
 sclerosis.  While individual results may vary, she has not suffered a relapse
 since 1998.
     The most common side effects of COPAXONE(R) are redness, pain, swelling,
 itching, or a lump at the site of injection, flushing, chest pain, weakness,
 infection, pain, nausea, joint pain, anxiety, and muscle stiffness.  These
 reactions are usually mild and seldom require professional treatment. Patients
 should tell their doctor about any
 side effects.
     Some patients report a short-term reaction right after injecting
 COPAXONE(R) (glatiramer acetate for injection).  This reaction can involve
 flushing (feeling of warmth and/or redness), chest tightness, or pain with
 heart palpitations, anxiety, and trouble breathing.  These symptoms generally
 appear within minutes of an injection, last about 15 minutes, and go away by
 themselves without further problems.
 
     Team COPAXONE(R)
     Booker is a member of Team COPAXONE(R).  She is just one example of
 someone who is living with relapsing-remitting multiple sclerosis and pursuing
 her dreams.  Team COPAXONE(R) celebrates the accomplishments of people like
 Booker who refuse to let MS stand in their way.  Members are working to change
 the perceptions that society holds of people living with multiple sclerosis.
 The days when people were sent home and told to go to bed and prepare for a
 wheelchair are at last disappearing.  Today a combination of lifestyle
 changes, medical management, and will power are helping people like Booker to
 live out their dreams.
     "Each mile that I run makes me feel empowered and proud of how I am
 managing my disease instead of letting it manage me," Booker stated.  "The
 26.2 miles in the Boston Marathon will help me demonstrate that those of us
 living with MS don't have to give up the things we love.  For me, that is
 running."
     Call 1-800-887-8100 for more information about COPAXONE(R) or multiple
 sclerosis.  Teva Neuroscience LLC markets COPAXONE(R).
     See additional important information at
 http://www.copaxone.com/pi/index.html or call 1-800-887-8100.
     COPAXONE(R) is a registered trademark of Teva Pharmaceutical Industries,
 Ltd.
     MSWatch(R) and Shared Solutions(TM) are trademarks of Teva Neuroscience
 LLC.
     323203/8372C1
     For product information, please call 1-800-753-0352 ext.738.
 
     CONTACT:  Jennifer Westphal of Fleishman-Hillard, 816-512-2241,
 westphaj@fleishman.com , for Teva Neuroscience LLC.
 
 SOURCE  Teva Neuroscience LLC